CHF
256.20
Change
-0.70 -0.27%
Volume
Volume 407,347
Mar 28, 2023, 2:47 p.m.
Quotes are delayed by 20 min
Previous close
CHF 256.90
CHF 256.20
Change
-0.70 -0.27%
Day low
Day high
CHF256.05
CHF257.95

52 week low
52 week high
CHF256.05
CHF404.20

Market cap
CHF207.21B
Average volume
1.53M
P/E ratio
16.64
Rev. per Employee
CHF610,744
EPS
15.40
Dividend
9.50
Div yield
3.71%
Ex dividend date
3/16/23
MarketWatch News on ROG
-
FDA committee backs Roche’s lymphoma treatment
- Mauro Orru
-
Merck & Co. Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Eli Lilly & Co. stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Amgen Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Abbott Laboratories stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Merck & Co. Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Eli Lilly & Co. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Amgen Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Abbott Laboratories stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Eli Lilly & Co. stock falls Monday, still outperforms market
- MarketWatch Automation
-
Amgen Inc. stock underperforms Monday when compared to competitors despite daily gains
- MarketWatch Automation
- Loading more headlines...
Other News on ROG
-
Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion
- The Wall Street Journal Interactive Edition
-
Bristol-Myers Reports Higher Sales, Earnings
- The Wall Street Journal Interactive Edition
-
Swiss Companies Battle Strong Franc
- The Wall Street Journal Interactive Edition
-
New Cancer Technology Cheers Investors
- The Wall Street Journal Interactive Edition
-
Roche Gets FDA Priority Review for Cancer Treatment
- The Wall Street Journal Interactive Edition
-
Roche Sees Profit, Sales Increasing
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Roche Wins Approval for Ebola Test
- The Wall Street Journal Interactive Edition
-
Roche Hit by Failure of Cancer Drug Trial
- The Wall Street Journal Interactive Edition
-
France Told To Do More for Investors
- The Wall Street Journal Interactive Edition
-
Roche’s Genentech Seeks Approval for Skin Cancer Drug
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Roche Names New Genentech R&D Chief
- The Wall Street Journal Interactive Edition
-
Merck Drug Shrank Tumors in Some Breast Cancer Patients
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Bristol-Myers Drug Shows Promise for Skin-Cancer Patients
- The Wall Street Journal Interactive Edition
-
Roche Holding AG May Submit Ebola Test For Emergency Use Approvals
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on ROG
No News currently available for ROG
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com